Join
Live feed
·
PRReleasevia Quantisnow
Ginkgo Bioworks Holdings Inc. logo

Ginkgo Bioworks Acquires Circularis to Strengthen Capabilities in Cell and Gene Therapy

ByQuantisnow·Wall Street's wire, on your screen.
DNA· Ginkgo Bioworks Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DNA (Ginkgo Bioworks Holdings Inc.) and more on Quantisnow.